MHC Class II Expression Restricted to CD8α+ and CD11b + Dendritic Cells Is Sufficient for Control of Leishmania major

Journal of Experimental Medicine

Volumn 199, Issue 5, 2004, Pages 725-730

  Lemos, Maria P ^a   Esquivel, Fatima ^a   Scott, Phillip ^a   Laufer, Terri M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antigen presentation; CD4; Langerhans cells; Macrophages; Th1

Indexed keywords

CD11B ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; LANGERHANS CELL; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD11B; ANTIGENS, CD8; CELL DIFFERENTIATION; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MACROPHAGE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TH1 CELLS;

EID: 1542373632     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030795     Document Type: Article

References (22)

1. Scott, P., and C.A. Hunter. 2002. Dendritic cells and immunity to leishmaniasis and toxoplasmosis. Curr. Opin. Immunol. 14:466-470.
2. Reiner, S.L., and R.M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
3. McElrath, M.J., G. Kaplan, A. Nusrat, and Z.A. Cohn. 1987. Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice. J. Exp. Med. 165:546-559.
4. Chakkalath, H.R., C.M. Theodos, J.S. Markowitz, M.J. Grusby, L.H. Glimcher, and R.G. Titus. 1995. Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease. J. Infect. Dis. 171:1302-1308.
5. + dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity. J. Immunol. 171:5077-5084.
6. Henri, S., J. Curtis, H. Hochrein, D. Vremec, K. Shortman, and E. Handman. 2002. Hierarchy of susceptibility of dendritic cell subsets to infection by Leishmania major: inverse relationship to interleukin-12 production. Infect. Immun. 70: 3874-3880.
7. + T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells. J. Exp. Med. 198:201-209.
8. von Stebut, E., Y. Belkaid, B.V. Nguyen, M. Cushing, D.L. Sacks, and M.C. Udey. 2000. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis. Eur. J. Immunol. 30:3498-3506.
9. Alexander, J., and D.G. Russell. 1992. The interaction of Leishmania species with macrophages. Adv. Parasitol. 31:175-254.
10. Wilhelm, P., U. Ritter, S. Labbow, N. Donhauser, M. Rollinghoff, C. Bogdan, and H. Korner. 2001. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J. Immunol. 166:4012-4019.
11. Diefenbach, A., H. Schindler, N. Donhauser, E. Lorenz, T. Laskay, J. MacMicking, M. Rollinghoff, I. Gresser, and C. Bogdan. 1998. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 8:77-87.
12. Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity. 4:275-281.
13. Campbell, K.A., P.J. Ovendale, M.K. Kennedy, W.C. Fanslow, S.G. Reed, and C.R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity. 4:283-289.
14. Rao, K.M. 2001. MAP kinase activation in macrophages. J. Leukoc. Biol. 69:3-10.
15. Macatonia, S.E., S.C. Knight, A.J. Edwards, S. Griffiths, and P. Fryer. 1987. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J. Exp. Med. 166:1654-1667.
16. Scott, P., E. Pearce, P. Natovitz, and A. Sher. 1987. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. J. Immunol. 139:221-227.
17. Vremec, D., and K. Shortman. 1997. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159:565-573.
18. Coffman, R.L., and K. Varkila. 1993. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. J. Immunol. 150:5476-5483.
19. Bacellar, O., C. Brownell, T. Regis, R.L. Coffman, S.G. Reed, and F. Powrie. 1994. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Immunol. 152:5949-5956.
20. + T cells in major histocompatibility complex class II-deficient mice. J. Exp. Med. 182:993-1004.
21. Ishikawa, H., H. Hisaeda, M. Taniguchi, T. Nakayama, T. Sakai, Y. Maekawa, Y. Nakano, M. Zhang, T. Zhang, M. Nishitani, et al. 2000. CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int. Immunol. 12:1267-1274.
22. Shankar, A.H., and R.G. Titus. 1997. The influence of antigen-presenting cell type and interferon-gamma on priming and cytokine secretion of Leishmania major-specific T cells. J. Infect. Dis. 175:151-157.